Profile

• 09/2008 - 03/2009: Post Graduate Diploma in Clinical Neurology. University College London, Institute of Neurology
• 09/1994 - 07/2000: Faculty of Medicine, National and Kapodistrian University of Athens

 

2015: PhD thesis led by A. Papadimitriou, Professor of Neurology, University of Thessaly. Title of the study: Detecting changes in brain’s white matter of patients with mild cognitive impairment, using diffusion tensor imaging. Grade: Excellent

 

• 2022 until today: Medical consultant at Langaware Inc (AI diagnosis supportive tool for neurodegenerative disorders)
• 09/2021 until today: Scientific associate at 1st Neurological Clinic at National University of Athens
• 3/2010-12/19: Consultant in Neurology Clinic of Euroclinic Athens Hospital
• 2/2006-11/2009: Senior House Officer in Neurology Clinic of Hellenic Red Cross Hospital in Athens

 

• Dementia, Neurodegenerative diseases
• Parkinson disease and other extrapyramidal syndromes

 

• 2009: Distinction for the Post Graduate Diploma in Clinical Neurology. University College London, Institute of Neurology
• 2008: Nominated by the Greek Neurologic Society

 

• 2022 Differences of apathy perfusion correlates between Alzheimer's disease and frontotemporal dementia. A 99mTc-HMPAO SPECT study with automated Brodmann areas analysis. Valotassiou V, Sifakis N, Tzavara C, Lykou E, Tsinia N, Kamtsadeli V, Sali D, Angelidis G, Psimadas D, Tsougos I, Papageorgiou SG, Georgoulias P, Papatriantafyllou J. Int J Psychiatry Clin Pract. 2022 Mar;26(1):14-22
• 2022 Anosognosia in Dementia: Evaluation of Perfusion Correlates Using 99mTc-HMPAO SPECT and Automated Brodmann Areas Analysis Varvara Valotassiou, Nikolaos Sifakis , Chara Tzavara, Evi Lykou , Niki Tsinia, Vasiliki Kamtsadeli, Dimitra Sali, George Angelidis , Dimitrios Psimadas, Eudoxia Theodorou , Ioannis Tsougos, Sokratis G. Papageorgiou , Panagiotis Georgoulias and John Papatriantafyllou. Diagnostics 2022, 12(5), 1136
• 2021 Eating Disorders in Frontotemporal Dementia and Alzheimer's Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis. Valotassiou V, Sifakis N, Tzavara C, Lykou E, Tsinia N, Kamtsadeli V, Sali D, Angelidis G, Psimadas D, Tsougos I, Papageorgiou SG, Georgoulias P, Papatriantafyllou J. J Alzheimers Dis. 2021;80(4):1657-1667
• 2021 Correlation of Neuropsychiatric Symptoms in Dementia with Brain Perfusion: A 99mTc-SPECT-HMPAO Study with Brodmann Areas Analysis. Valotassiou V, Sifakis N, Tzavara C, Lykou E, Tsinia N, Kamtsadeli V, Sali D, Angelidis G, Psimadas D, Tsougos I, Papageorgiou SG, Georgoulias P, Papatriantafyllou J. Curr Alzheimer Res. 2021;18(12):970-983.
• 2021 The impact of COVID‐19 pandemic on people with mild cognitive impairment/dementia and on their caregivers Angeliki Tsapanou1,| John D. Papatriantafyllou, Konstantina Yiannopoulou, Dimitra Sali, Fedra Kalligerou, Eva Ntanasi, Panagiota Zoi, Eleni Margioti,Vasiliki Kamtsadeli,Maria Hatzopoulou, Maria Koustimpi, Athina Zagka, Sokratis G. Papageorgiou, Paraskeui Sakka.
  Int J Geriatr Psychiatry. 2021;36:583–587

• Member of the Medical Society of Athens
• Member of the Greek Neurology Society
• Member of the Hellenic Dementia Association

 

• 2021 until today: NN6535-4730 A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE)
• 2014: Μ1-793 A randomised double-blind placebo-controlled clinical trial investigating the effect and safety ABT-126 in subjects with mild to moderate Alzheimer´s disease under stable dosing of AChE inhibitors